Use of double marking with retroviral vectors to determine rate of reconstitution of untreated and cytokine expanded CD34+ selected marrow cells in patients undergoing autologous bone marrow transplantation.
Heslop
H E
HE
Division of Bone Marrow Transplantation, St. Jude Children's Research Hospital, Memphis, Tennessee 38101-0318, USA.
Brenner
M K
MK
Krance
R A
RA
Bowman
L
L
Cunningham
J M
JM
Richardson
S
S
Alexander
B
B
Heideman
R
R
Boyett
J M
JM
Srivastava
D K
DK
Marcus
S G
SG
Berenson
R
R
Heimfeld
S
S
Brown
S
S
D018952:Antigens, CD34; D001853:Bone Marrow / Q000187:drug effects / Q000276:immunology; D001854:Bone Marrow Cells; D016026:Bone Marrow Transplantation; D002648:Child; D002985:Clinical Protocols; D016207:Cytokines / Q000494:pharmacology; D005819:Genetic Markers / Q000235:genetics*; D005822:Genetic Vectors; D006801:Humans; D009369:Neoplasms / Q000276:immunology / Q000628:therapy*; D012190:Retroviridae / Q000235:genetics*; D014182:Transplantation, Autologous
D018952:Antigens, CD34; D016207:Cytokines; D005819:Genetic Markers